Examining the Use of Real‐World Evidence in the Regulatory Process
Top Cited Papers
Open Access
- 28 September 2019
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 107 (4), 843-852
- https://doi.org/10.1002/cpt.1658
Abstract
The 21st Century Cures Act passed by the United States Congress mandates the US Food and Drug Administration to develop guidance to evaluate the use of real‐world evidence (RWE) to support the regulatory process. RWE has generated important medical discoveries, especially in areas where traditional clinical trials would be unethical or infeasible. However, RWE suffers from several issues that hinder its ability to provide proof of treatment efficacy at a level comparable to randomized controlled trials. In this review article, we summarized the advantages and limitations of RWE, identified the key opportunities for RWE, and pointed the way forward to maximize the potential of RWE for regulatory purposes.Keywords
Funding Information
- U.S. National Library of Medicine (T15LM007092)
- National Institute of General Medical Sciences (T32GM007753)
This publication has 105 references indexed in Scilit:
- Data-Driven Prediction of Drug Effects and InteractionsScience Translational Medicine, 2012
- Outcome-Adaptive Randomization: Is It Useful?Journal of Clinical Oncology, 2011
- Negative ControlsEpidemiology, 2010
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsThe Pharmacogenomics Journal, 2010
- Multiply Robust Inference for Statistical InteractionsJournal of the American Statistical Association, 2008
- Value based pricing for NHS drugs: an opportunity not to be missed?BMJ, 2008
- The Hawthorne Effect: a randomised, controlled trialBMC Medical Research Methodology, 2007
- Challenges of Using Medical Insurance Claims Data for Utilization AnalysisAmerican Journal of Medical Quality, 2006
- Adherence to MedicationThe New England Journal of Medicine, 2005
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983